Glucose as a prognostic factor in ovarian carcinoma
- 作者Donald M. Lamkin; Douglas R. Spitz; Mian M. K. Shahzad; Bridget Zimmerman; Daniel J. Lenihan; Koen DeGeest; David M. Lubaroff; Eileen H. Shinn; Anil K. Sood; Susan K. Lutgendorf
- 卷第115卷
- 期第5期
- 印刷ISSN0008-543X
- 电子ISSN1097-0142
- 文件大小163.04KB
- 发表时间2009
- DOI10.1002/cncr.24126
- 页码1021-1027
Prolymphocytic leukemiaAhmed Absi; Eric Hsi; Matt Kalaycio · 2005
The role of parenteral nutritionNicole B. Jacobson; Neha Parekh; Matt Kalaycio · 2006
Perspectives in Oncology Drug PricingStevenson, James P.; Kalaycio, Matt; Bolwell, Brian · JAMA Oncology · 2016
Clinical Significance of Cytogenetics in Myeloproliferative DisordersSuppiah, Revathi; Shah, Jigar; Kalaycio, Matt · Laboratory Medicine · 2007
Clinical Significance of Cytogenetics in Myelodysplastic SyndromesHaddad, Abdo; Maciejewski, Jaroslaw P.; Kalaycio, Matt · Laboratory Medicine · 2008
Treatment of refractory and relapsed acute myelogenous leukemiaStanisic, Slobodan; Kalaycio, Matt · Expert Review of Anticancer Therapy · 2002
Clinical Significance of Cytogenetics in Myeloproliferative DisordersSuppiah, Revathi; Shah, Jigar; Kalaycio, Matt · Laboratory Medicine · 2007